In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast Cancer

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

November 29, 2021

Study Completion Date

December 31, 2021

Conditions
Breast Neoplasms
Interventions
DIAGNOSTIC_TEST

ARNA Breast

Women of the required age group, in case of suspicion of breast cancer, are sent to clarify the diagnosis for mammography or ultrasound of the mammary glands, or MRI. Based on the results of these studies, a biopsy is prescribed to make a final diagnosis. Before a biopsy to diagnose the presence / absence of breast cancer, patients do the blood sampling one time. The blood is processed in the Sponsor's laboratory. The test results are compared with the data obtained from the biopsy. The evaluation of the effectiveness of the method will be determined on the basis of the obtained data on the sensitivity and specificity of the test in relation to the reference method

Sponsors
All Listed Sponsors
collaborator

BIOMARKER-RU

UNKNOWN

lead

ARNA Genomics US Inc.

INDUSTRY